Circulating leptin, soluble leptin receptor, free leptin index, visfatin and selected leptin and leptin receptor gene polymorphisms in sporadic breast cancer. 2017

Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Colombo 03, 00300, Sri Lanka.

Leptin and visfatin are implicated in breast cancer risk but studies accounting for bioavailability of leptin are sparse. Reports on the association of leptin gene (LEP) and leptin receptor gene (LEPR) polymorphisms with breast cancer are also inconsistent. Only a very few studies have examined biochemical and genetic variables concomitantly in the same cohort. A matched pairs study was carried out to ascertain whether plasma leptin, soluble leptin receptor, free leptin index (leptin/soluble leptin receptor), serum visfatin and selected LEP and LEPR polymorphisms are risk factors for sporadic breast cancer. Newly diagnosed sporadic breast cancer patients (N=80) were matched for age, body mass index (BMI) and menopausal status with healthy controls. Plasma leptin, soluble leptin receptor and serum visfatin were measured by enzyme-immunoassay. LEP -2548 A/G and LEPR K109R, LEPR Q223R polymorphisms were determined by genotyping. Leptin (p=0.0234), leptin/BMI (p=0.0468), free leptin index (p<0.0001) and visfatin (p=0.0002) were significantly higher and soluble leptin receptor (p<0.0001) was significantly lower in patients. LEPR gene K109R A/G polymorphism increased breast cancer risk (odds ratio: 4.125). Multivariate analysis confirmed that leptin, soluble leptin receptor, free leptin index and G109 (R109) allele of the LEPR gene K109R polymorphism are risk factors for breast cancer. When stratified by menopausal status free leptin index and soluble leptin receptor remained as risk factors irrespective of menopausal status while LEPR gene K109R A/G polymorphism remained as a risk factor only in the postmenopausal group.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
October 2002, The Journal of clinical endocrinology and metabolism,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
August 2021, Minerva anestesiologica,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
March 2018, DNA and cell biology,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
June 2006, Cancer letters,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
January 2008, Biological trace element research,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
July 2001, International journal of cancer,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
February 2004, Fertility and sterility,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
August 2007, Ginekologia polska,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
January 2008, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,
Chrishani Rodrigo, and Kamani Hemamala Tennekoon, and Eric Hamilton Karunanayake, and Kanishka De Silva, and Indrani Amarasinghe, and Ananda Wijayasiri
March 2020, Pediatric gastroenterology, hepatology & nutrition,
Copied contents to your clipboard!